← Back to Search

CADS for Diabetes (CADS Trial)

N/A
Waitlist Available
Research Sponsored by Walter Reed Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

The primary purpose of this study is to determine whether the use of a computer assisted decision support (CADS)system by primary care providers (PCPs) for their patients with type 2 diabetes mellitus (T2DM) changes the quality of care relative to a "usual care" group in terms of objective outcome measures of glycemic control (e.g., A1C, mean blood glucose, frequency of hypoglycemic episodes) and in terms of subjective ratings by patients.

Eligible Conditions
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Improved glycemic control as determined by A1C in a population of patients with inadequately controlled type 2 diabetes mellitus.
Secondary study objectives
Blood pressure
Lipid levels
Number of major and minor hypoglycemic episodes in the intervention and control groups.
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CADSExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of HawaiiOTHER
120 Previous Clinical Trials
54,580 Total Patients Enrolled
1 Trials studying Diabetes
107 Patients Enrolled for Diabetes
Walter Reed Army Medical CenterLead Sponsor
69 Previous Clinical Trials
20,369 Total Patients Enrolled
59th Medical WingFED
40 Previous Clinical Trials
12,080 Total Patients Enrolled
~40 spots leftby Nov 2025